FR2451191A1 - THERAPEUTIC COMPOSITIONS BASED ON HYDROXYL DERIVATIVES OF ISOPROPYLAMINO-2 PYRIMIDINE - Google Patents

THERAPEUTIC COMPOSITIONS BASED ON HYDROXYL DERIVATIVES OF ISOPROPYLAMINO-2 PYRIMIDINE

Info

Publication number
FR2451191A1
FR2451191A1 FR8005277A FR8005277A FR2451191A1 FR 2451191 A1 FR2451191 A1 FR 2451191A1 FR 8005277 A FR8005277 A FR 8005277A FR 8005277 A FR8005277 A FR 8005277A FR 2451191 A1 FR2451191 A1 FR 2451191A1
Authority
FR
France
Prior art keywords
therapeutic compositions
isopropylamino
pyrimidine
hydroxyl derivatives
compositions based
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8005277A
Other languages
French (fr)
Other versions
FR2451191B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ugine Kuhlmann SA
Original Assignee
Ugine Kuhlmann SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26270867&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR2451191(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ugine Kuhlmann SA filed Critical Ugine Kuhlmann SA
Publication of FR2451191A1 publication Critical patent/FR2451191A1/en
Application granted granted Critical
Publication of FR2451191B1 publication Critical patent/FR2451191B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'INVENTION CONCERNE DES COMPOSITIONS THERAPEUTIQUES CONTENANT COMME PRINCIPE ACTIF AU MOINS UN DES DERIVES HYDROXYLES DE L'ISOPROPYLAMINO-2 PYRIMIDINE DE FORMULE GENERALE: (CF DESSIN DANS BOPI) DANS LAQUELLE A, A ET A REPRESENTENT CHACUN: -UN ATOME D'HYDROGENE; -UN RADICAL HYDROXY, AVEC LA RESTRICTION QU'AU MOINS L'UN DES SUBSTITUANTS A, A ET A N'EST PAS UN ATOME D'HYDROGENE, ASSOCIE A UN EXCIPIENT APPROPRIE, AINSI QUE DES COMPOSITIONS THERAPEUTIQUES SELON LA REVENDICATION 1 COMPORTANT DE 1 A 20MG DE PRINCIPE ACTIF PAR UNITE DE DOSAGE.THE INVENTION CONCERNS THERAPEUTIC COMPOSITIONS CONTAINING AS ACTIVE PRINCIPLE AT LEAST ONE OF THE HYDROXYL DERIVATIVES OF 2-ISOPROPYLAMINO-PYRIMIDINE OF GENERAL FORMULA: (CF DRAWING IN BOPI) IN WHICH A, A AND A REPRESENTROGENE EACHH: -DUN: -DUN ; -A RADICAL HYDROXY, WITH THE RESTRICTION THAT AT LEAST ONE OF THE SUBSTITUTES A, A AND A IS NOT A HYDROGEN ATOM, ASSOCIATED WITH A SUITABLE EXCIPIENT, AS WELL AS THERAPEUTIC COMPOSITIONS ACCORDING TO CLAIM 1 INCLUDING 1 AT 20MG OF ACTIVE PRINCIPLE PER DOSAGE UNIT.

FR8005277A 1979-03-10 1980-03-10 THERAPEUTIC COMPOSITIONS BASED ON HYDROXYL DERIVATIVES OF ISOPROPYLAMINO-2 PYRIMIDINE Granted FR2451191A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7908494 1979-03-10
GB7914987 1979-04-30

Publications (2)

Publication Number Publication Date
FR2451191A1 true FR2451191A1 (en) 1980-10-10
FR2451191B1 FR2451191B1 (en) 1983-04-29

Family

ID=26270867

Family Applications (2)

Application Number Title Priority Date Filing Date
FR8005278A Granted FR2451370A1 (en) 1979-03-10 1980-03-10 HYDROXYL DERIVATIVES OF ISOPROPYLAMINO-2 PYRIMIDINE AND THEIR PREPARATION
FR8005277A Granted FR2451191A1 (en) 1979-03-10 1980-03-10 THERAPEUTIC COMPOSITIONS BASED ON HYDROXYL DERIVATIVES OF ISOPROPYLAMINO-2 PYRIMIDINE

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR8005278A Granted FR2451370A1 (en) 1979-03-10 1980-03-10 HYDROXYL DERIVATIVES OF ISOPROPYLAMINO-2 PYRIMIDINE AND THEIR PREPARATION

Country Status (24)

Country Link
JP (1) JPS55122768A (en)
AR (1) AR222691A1 (en)
AU (1) AU533547B2 (en)
BE (1) BE881752A (en)
CA (1) CA1132561A (en)
CH (1) CH644368A5 (en)
DE (3) DE3009071C2 (en)
EG (1) EG14282A (en)
FI (1) FI66357C (en)
FR (2) FR2451370A1 (en)
GB (1) GB2045756B (en)
HK (1) HK55383A (en)
IE (1) IE49547B1 (en)
IN (1) IN153791B (en)
LU (1) LU82185A1 (en)
MX (1) MX6218E (en)
MY (1) MY8400200A (en)
NL (1) NL184833C (en)
NO (1) NO154054C (en)
NZ (1) NZ192927A (en)
OA (1) OA06484A (en)
PT (1) PT70882A (en)
SE (1) SE435180B (en)
SG (1) SG22683G (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE894517A (en) * 1981-10-16 1983-01-17 Sod Conseils Rech Applic NEW ISOPROPYLAMINO PYRIMIDINE DERIVATIVE, ITS PREPARATION AND THERAPEUTIC COMPOSITION BASED ON ITS COMPOUNDS
US4673677A (en) * 1983-10-03 1987-06-16 Pfizer Inc. Method for treatment of gastrointestinal disorders
US4554276A (en) * 1983-10-03 1985-11-19 Pfizer Inc. 2-Amino-5-hydroxy-4-methylpyrimidine derivatives
US4711888A (en) 1985-07-24 1987-12-08 Pfizer Inc. Hydroxy and alkoxy pyrimidines
WO1989000423A1 (en) * 1987-07-09 1989-01-26 Pfizer Inc. 2-amino-5-hydroxy-4-pyrimidones
US4910204A (en) * 1988-06-28 1990-03-20 Pfizer Inc. 2-amino-5-hydroxy-4-pyrimidones
HU206337B (en) * 1988-12-29 1992-10-28 Mitsui Petrochemical Ind Process for producing pyrimidine derivatives and pharmaceutical compositions
US5264435A (en) * 1988-12-29 1993-11-23 Mitsui Petrochemical Industries, Ltd. Pyrimidines and their pharmaceutical acceptable salts, and their use as medicines
US4940712A (en) * 1989-05-26 1990-07-10 Pfizer Inc. Derivatives of hydroxyprimidines as leukotriene synthesis inhibitors
US5270319A (en) * 1991-09-09 1993-12-14 Warner-Lambert Company 5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents
US5220025A (en) * 1992-02-24 1993-06-15 Warner-Lambert Company 2-substituted amino-4, 6-di-tertiary-butyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
US5196431A (en) * 1992-02-24 1993-03-23 Warner-Lambert Company 2-substituted amino-4, 6-di-tertiary-buthyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
US9133212B1 (en) * 2005-06-15 2015-09-15 Vanderbilt University Inhibitors of hemeprotein-catalyzed lipid peroxidation

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB756189A (en) * 1954-02-01 1956-08-29 Ici Ltd New pyrimidine derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB741667A (en) * 1952-12-05 1955-12-07 Ici Ltd New pyrimidine derivatives
ZA711152B (en) * 1970-03-02 1971-11-24 Ici Ltd Manufacture of pyrimidines
GB1525995A (en) * 1976-02-18 1978-09-27 Soc D Etudes Prod Chimique Aminopyrimidine salt

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB756189A (en) * 1954-02-01 1956-08-29 Ici Ltd New pyrimidine derivatives

Also Published As

Publication number Publication date
BE881752A (en) 1980-05-30
NL184833C (en) 1989-11-16
GB2045756A (en) 1980-11-05
LU82185A1 (en) 1980-06-06
SE435180B (en) 1984-09-10
IE800477L (en) 1980-09-10
AU5624880A (en) 1980-09-18
PT70882A (en) 1980-03-01
FI66357C (en) 1984-10-10
FR2451370A1 (en) 1980-10-10
JPS6126996B2 (en) 1986-06-23
NZ192927A (en) 1981-07-13
FI66357B (en) 1984-06-29
DE3016752C2 (en) 1987-06-25
GB2045756B (en) 1983-01-26
MX6218E (en) 1984-12-21
DE3050999A1 (en) 1985-08-14
JPS55122768A (en) 1980-09-20
DE3009071A1 (en) 1980-09-11
FR2451191B1 (en) 1983-04-29
HK55383A (en) 1983-11-25
MY8400200A (en) 1984-12-31
NO154054C (en) 1986-07-09
IN153791B (en) 1984-08-18
CA1132561A (en) 1982-09-28
AU533547B2 (en) 1983-12-01
AR222691A1 (en) 1981-06-15
NL184833B (en) 1989-06-16
DE3016752A1 (en) 1980-12-04
CH644368A5 (en) 1984-07-31
SG22683G (en) 1983-12-16
SE8001812L (en) 1980-09-11
NL8001289A (en) 1980-09-12
DE3009071C2 (en) 1985-11-14
NO154054B (en) 1986-04-01
NL184468B (en) 1989-03-01
FR2451370B1 (en) 1983-05-13
IE49547B1 (en) 1985-10-30
EG14282A (en) 1983-09-30
NO800664L (en) 1980-09-11
DE3050999C2 (en) 1986-08-14
OA06484A (en) 1981-07-31
FI800566A (en) 1980-09-11

Similar Documents

Publication Publication Date Title
FR2451191A1 (en) THERAPEUTIC COMPOSITIONS BASED ON HYDROXYL DERIVATIVES OF ISOPROPYLAMINO-2 PYRIMIDINE
TW228515B (en)
DK341187A (en) VIRUCID AGENT WITH WIDE-SPECIFIC EFFECTS
CA2085192A1 (en) Fungicidal derivatives of 2-imidazoline-5-ones and 2-imidazoline-5-thiones
FR2361901A1 (en) NUCLEOTIDES SUBSTITUTION DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING THESE SUBSTANCES
GB2210556B (en) The use of 15-keto-16-halo-prostaglandins in cathartic compositions
TNSN89103A1 (en) [(DIARYLMETHOXY) ALCOYL] -1 PYRROLIDINES AND PIPERIDINES AND PROCESSES FOR THEIR PREPARATION
FR2447375A1 (en) PROSTAGLANDIN E1 ANALOGS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2413370A1 (en) TRANS-4A-ARYL-OCTAHYDRO-1H-2-PYRINDINS AND THEIR THERAPEUTIC USE
FR2400035A1 (en) STEROID DERIVATIVES AND THEIR USE IN RADIO-IMMUNO-TESTS
ES426040A1 (en) Vinvamine series cycloalkyl-alkyl esters
ES2002207A6 (en) Glucosylmoranoline derivatives and use thereof for inhibiting increase in blood sugar levels
FR2450835A2 (en) TETRAHYDROALSTONIN DERIVATIVES AND THEIR THERAPEUTIC APPLICATION
FR2359116A1 (en) N-ALKYLDIPHENYLAMINES
FR2455588A1 (en) PREPARATION OF HYDROXYL DERIVATIVES OF ISOPROPYLAMINO-PYRIMIDINE (HYDROGEN REDUCTION SEQUENCE)
FR2637500A1 (en) DRUGS BASED ON NEW DERIVATIVES OF CARBONYL-2 N, N'-DI- (TRIMETHOXYBENZOYLE) PIPERAZINE
FR2433553A1 (en) RESINS OF UNSATURATED POLYESTERS, NOT INHIBITED BY AIR OXYGEN, THEIR PREPARATION AND THEIR USES
FR2637499A1 (en) MEDICINES BASED ON NEW DERIVATIVES OF METHOXYCARBONYL-2 N, N'-DI- (TRIMETHOXYBENZOYLE) PIPERAZINE
FR2360560A1 (en) D-THREO-1-PHENYL-2-TRIFLUORACETAMIDO-1,3-PROPANE-DIOL DERIVATIVES AND THEIR APPLICATIONS AS ANTIBIOTICS
Hubbard et al. Effects of pyribenzamine on the respiration of mouse brain homogenates
ES8304111A1 (en) 2,6-Diethyl-3,5-dimethyl-2,3-dihydro-4H-pyran, process for its preparation and its use in the early identification and location of and in combating Lasioderma serricorne F.
BE905784A (en) CARBAMOYLOXYMETHYLALCOYLCARBAPENEMES.
BE902610A (en) NOVEL ANTHRACYCLINES AND THEIR MANUFACTURING PROCESS.
FR2361393A1 (en) (2-AZABICYCLO (2.2.2) OCTANE-2-YL) DIPHENYLALCANONES AND DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USES, ESPECIALLY AS ANTI-DIARRHEA
FR2429202A1 (en)

Legal Events

Date Code Title Description
ST Notification of lapse